Long-Term Prognostic Value of Myocardial Fibrosis in Patients With Chagas Cardiomyopathy

被引:64
|
作者
Senra, Tiago [1 ,2 ]
Ianni, Barbara M. [1 ]
Costa, Ana C. P. [1 ]
Mady, Charles [1 ]
Martinelli-Filho, Martino [1 ]
Kalil-Filho, Roberto [1 ]
Rochitte, Carlos E. [1 ]
机构
[1] Univ Sao Paulo, Sch Med, Heart Inst InCor, Ave Dr Eneas de Carvalho Aguiar 44, BR-05403000 Sao Paulo, SP, Brazil
[2] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
cardiac magnetic resonance; Chagas cardiomyopathy; myocardial fibrosis; prognosis; delayed enhancement; MORTALITY; DISEASE; QUANTIFICATION; PREDICTORS; DEATH;
D O I
10.1016/j.jacc.2018.08.2195
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Myocardial fibrosis (MF) according to cardiac magnetic resonance (CMR) is a frequent finding in Chagas cardiomyopathy and has been associated with risk factors of poor outcome. OBJECTIVES The goal of this study was to determine the prognostic value of MF in predicting combined hard events or all-cause mortality. METHODS Patients with Chagas cardiomyopathy who had a previous CMR evaluation were included, and clinical follow-up was retrospectively obtained. The primary outcome was a combination of all-cause mortality, heart transplantation, antitachycardia pacing or appropriate shock from an implantable cardioverter-defibrillator, and aborted sudden cardiac death; the secondary outcome was all-cause mortality. RESULTS A total of 130 patients were included; mean age was 53.6 +/- 11.5 years, and 53.9% were female. The majority of patients reported no symptoms of heart failure or arrhythmia, but electrocardiographic and echocardiographic abnormalities were common. On CMR, left ventricular dilatation and dysfunction were frequent, and MF was found in 76.1%, with a mean mass of 15.2 +/- 16.5 g. Over a median follow-up of 5.05 years, 58 (44.6%) patients reached the combined endpoint, and 45 (34.6%) patients died. MF was associated with the primary outcome as a continuous variable (adjusted hazard ratio: 1.031; 95% CI: 1.013 to 1.049; p = 0.001) and as a categorical variable (MF >= 12.3 g) (adjusted hazard ratio: 2.107; 95% CI: 1.111 to 3.994; p = 0.022), independently from the Rassi risk score. MF expressed as a continuous variable was also associated with all-cause mortality (adjusted hazard ratio: 1.028; 95% CI: 1.005 to 1.051; p = 0.017) independently from the Rassi risk score. CONCLUSIONS MF is an independent predictor of adverse outcome in Chagas cardiomyopathy. Our data may support the use of CMR in better risk-stratifying this population and possibly guiding therapy. (c) 2018 by the American College of Cardiology Foundation.
引用
收藏
页码:2577 / 2587
页数:11
相关论文
共 50 条
  • [41] The Importance of Understanding the Progression of Myocardial Fibrosis in Chronic Chagas Cardiomyopathy
    Rochitte, Carlos E.
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2021, 117 (06) : 1091 - 1092
  • [42] Long-term prognostic value of semi- quantitative myocardial perfusion imaging in patients with homozygous familial hypercholesterolemia
    Jiao, J.
    Dong, W.
    Mou, T.
    Mi, H.
    Zhang, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S603 - S603
  • [43] Prognostic value of myocardial perfusion abnormalities for long-term prognosis in patients after coronary artery bypass grafting
    Milvidaite, Irena
    Kulakiene, Ilona
    Vencloviene, Jone
    Kinduris, Sarunas
    Jurkiene, Nemira
    Grizas, Vytautas
    Navickas, Ramunas
    Slapikas, Rimvydas
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2014, 29 (04): : 222 - 226
  • [44] Long-term prognostic value of high-sensitivity cardiac troponin-I in patients with idiopathic dilated cardiomyopathy
    Wang, Yongchao
    Wang, Xiaolin
    Yang, Yulin
    Xu, Hao
    Li, Jian
    OPEN MEDICINE, 2023, 18 (01):
  • [45] Long-term prognostic value of myocardial contrast echocardiography during supine bicycle stress
    Miszalski-Jamka, T.
    Kuntz-Hehner, S.
    Schmidt, H.
    Peter, D.
    Miszalski-Jamka, K.
    Hammerstingl, C.
    Omran, H.
    EUROPEAN HEART JOURNAL, 2007, 28 : 623 - 623
  • [46] Long-term prognostic value of myocardin expression levels in non-ischemic dilated cardiomyopathy
    Maria E. Marketou
    Joanna Kontaraki
    Alexandros Patrianakos
    Emmanuel Kanoupakis
    Anthoula Plevritaki
    Hercules Mavrakis
    Eleutherios Kallergis
    Emmanuel Koutalas
    Ioannis Anastasiou
    Gregory Chlouverakis
    Fragiskos Parthenakis
    Heart and Vessels, 2021, 36 : 1841 - 1847
  • [47] Long-term prognostic value of ultrastructural features in dilated cardiomyopathy: comparison with cardiac magnetic resonance
    Saito, Tsunenori
    Asai, Kuniya
    Tachi, Masaki
    Sato, Shigeru
    Mozawa, Kosuke
    Adachi, Akiko
    Sasaki, Yoshihiro
    Amano, Yasuo
    Mizuno, Kyoichi
    Kumita, Shin-ichiro
    Shimizu, Wataru
    ESC HEART FAILURE, 2020, 7 (02): : 682 - 691
  • [48] Long-term prognostic value of myocardin expression levels in non-ischemic dilated cardiomyopathy
    Marketou, Maria E.
    Kontaraki, Joanna
    Patrianakos, Alexandros
    Kanoupakis, Emmanuel
    Plevritaki, Anthoula
    Mavrakis, Hercules
    Kallergis, Eleutherios
    Koutalas, Emmanuel
    Anastasiou, Ioannis
    Chlouverakis, Gregory
    Parthenakis, Fragiskos
    HEART AND VESSELS, 2021, 36 (12) : 1841 - 1847
  • [49] Value of Genetic Testing for the Prediction of Long-Term Outcome in Patients With Hypertrophic Cardiomyopathy
    van Velzen, Hannah G.
    Vriesendorp, Pieter A.
    Oldenburg, Rogier A.
    van Slegtenhorst, Marjon A.
    van der Velden, Jolanda
    Schinkel, Arend F. L.
    Michels, Michelle
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (06): : 881 - 887
  • [50] Left ventricular remodeling behavior of patients with Chagas cardiomyopathy and pacemaker in a long-term follow-up
    Peixoto, G.
    Martinelli, M.
    Siqueira, S. F.
    Madia, R. O.
    Lensi, M. M.
    Nishioka, S. A. D.
    Teixeira, R. A.
    Pedrosa, A. A. A.
    Costa, R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 89 - 89